TCWP’s Boston Scientific BSX Stock Holding History

TCWP’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,308	Closed	-$57K	–	488
2022 Q1	$57K	Buy	+1,308	New	+$56.7K	0.01%	451

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

TCWP's BSX Position: Q2 2022 in Review

TCWP sold out of Boston Scientific (BSX) in Q2 2022, closing a stake of 1,308 shares — an estimated $57K sold.

TCWP first reported a position in BSX in Q1 2022 and held it in 1 quarter. The position peaked at $57K in Q1 2022. 878 funds tracked by Wall St. Rank hold BSX as of Q2 2022.

TCWP reported no remaining Boston Scientific position as of Q2 2022 after selling out during the quarter.
TCWP sold 1,308 Boston Scientific shares in Q2 2022, an estimated $57K.
TCWP first reported a position in Boston Scientific in Q1 2022 and held it in 1 quarter.
TCWP's Boston Scientific position peaked at $57K in Q1 2022.
878 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2022.

Based on TCWP's 13F filing for Q2 2022, filed 15 Aug 2022.